Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Aimovig 140mg


To avoid
As a precautionary measure

May be acceptable
If it is considered to be clearly essential
Aimovig 140mg :
Type Medicine Non Marketed
Originator B
Agent Khalil Fattal & Fils
Distributor Khalil Fattal & Fils
Laboratory Novartis
Responsible Party Novartis Pharma AG
Origin Switzerland
Manufacturer Amgen Manufacturing Ltd
Origin U.S.A.
ATC N02CX07

Your comment will appear shortly after approval

Aimovig 140mg :

Revision Date : 01/03/22


Effect Frequency
Alopecia Not known
Anaphylaxis Common
Angioedema (Angioneurotic oedema) (Quincke oedema) Common
Blister Not known
Constipation Common
Exfoliative rash Not known
Hypersensitivity reactions Common
Injection site reaction Common
Mouth ulceration Not known
Muscle spasms Common
Oedema Common
Oral mucosal blistering (Oral mucosa blister) Not known
Pruritus Common
Rash erythematous Not known
Rash papular Not known
Skin rash Common
Stomatitis Not known
Swelling Common
Urticaria Common

Different Units By MoH Code

Revision Date : 01/03/2022

Revision Date : 01/03/2022

Aimovig 140mg  MoH 10428 :
Form Solution for injection
Packaging Pen with encased glass type I syringe
Package Size 1x1ml
Package Content 1 pre-filled pen (1 ml, Type 1 glass) with a stainless steel needle and a needle cover (rubber containing latex).
Strength 140mg
Storage Condition 2-8°C Do not freeze
NSSF ✘
Quarantine ✘
Reg. Number 176419/1
Submission date 2020
Registration Year 01/02/2021
Archived Date 12/12/2024


Price Comparison

● Country: France
● Package Size: 1
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info